Compare AANJANEYA LIFECARE with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ELDER PHARMA DR. DATSONS LABS/
ELDER PHARMA
 
P/E (TTM) x -10.9 -0.2 - View Chart
P/BV x 0.2 0.1 160.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ELDER PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ELDER PHARMA
Jun-14
DR. DATSONS LABS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs126380 33.1%   
Low Rs31188 16.4%   
Sales per share (Unadj.) Rs133.0491.2 27.1%  
Earnings per share (Unadj.) Rs0.2-3.2 -4.8%  
Cash flow per share (Unadj.) Rs6.614.4 45.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.8376.5 34.2%  
Shares outstanding (eoy) m31.6620.54 154.1%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.6 101.8%   
Avg P/E ratio x516.1-89.3 -578.2%  
P/CF ratio (eoy) x11.819.7 60.1%  
Price / Book Value ratio x0.60.8 80.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4775,833 42.5%   
No. of employees `000NANA-   
Total wages/salary Rs m562,179 2.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m4,21110,089 41.7%  
Other income Rs m79257 30.7%   
Total revenues Rs m4,28910,346 41.5%   
Gross profit Rs m569-792 -71.8%  
Depreciation Rs m204361 56.6%   
Interest Rs m4302,756 15.6%   
Profit before tax Rs m13-3,653 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m6125 4.9%   
Profit after tax Rs m5-65 -7.3%  
Gross profit margin %13.5-7.8 -172.0%  
Effective tax rate %48.0-3.4 -1,402.0%   
Net profit margin %0.1-0.6 -17.6%  
BALANCE SHEET DATA
Current assets Rs m6,8529,240 74.2%   
Current liabilities Rs m6,7119,998 67.1%   
Net working cap to sales %3.3-7.5 -44.6%  
Current ratio x1.00.9 110.5%  
Inventory Days Days16146 347.3%  
Debtors Days Days31860 531.3%  
Net fixed assets Rs m3,67310,124 36.3%   
Share capital Rs m317206 153.9%   
"Free" reserves Rs m3,7615,582 67.4%   
Net worth Rs m4,0787,734 52.7%   
Long term debt Rs m1,6714,889 34.2%   
Total assets Rs m12,63322,882 55.2%  
Interest coverage x1.0-0.3 -316.5%   
Debt to equity ratio x0.40.6 64.8%  
Sales to assets ratio x0.30.4 75.6%   
Return on assets %3.411.8 29.3%  
Return on equity %0.1-0.8 -13.9%  
Return on capital %7.722.3 34.4%  
Exports to sales %22.93.0 753.4%   
Imports to sales %14.30.4 3,346.3%   
Exports (fob) Rs m964307 314.4%   
Imports (cif) Rs m60243 1,396.5%   
Fx inflow Rs m964307 314.4%   
Fx outflow Rs m607125 484.5%   
Net fx Rs m357181 196.9%   
CASH FLOW
From Operations Rs m1,34511,754 11.4%  
From Investments Rs m-2,256-561 402.4%  
From Financial Activity Rs m-1,200-6,762 17.7%  
Net Cashflow Rs m-2,1114,432 -47.6%  

Share Holding

Indian Promoters % 4.5 39.6 11.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 1.4 16.8 8.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 36.1 260.7%  
Shareholders   20,807 16,479 126.3%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   JUBILANT PHARMOVA   PANACEA BIOTECH  FDC  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Plunged 1,708 Points Today(Closing)

Indian share markets witnessed huge selling pressure today as fears that the government could go for stricter lockdowns.

Related Views on News

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - ALEMBIC PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS